Dechra have now released their interim results for the year ending 2019. Revenues increased when compared to the first half of last year due to a £21.9M growth in European revenue and a £15.4M increase in North American Revenue. Cost … Continue reading
Category Archives: Dechra Pharmaceuticals
Dechra Pharmaceuticals have now released their final results for the year ended 2018. Revenues increased when compared to the last year due to a £31.8M growth in European revenue and a £16.1M increase in North American revenue. Cost of sales … Continue reading
Dechra Pharmaceuticals have now released their interim results for the year ending 2018. Revenues increased when compared to the first half of last year with an £11.3M growth in North American sales and a £10.2M increase in European sales. Cost … Continue reading
Dechra Pharmaceuticals has now released their final results for the year ended 2017. Revenues increased when compared to last year with a £73.6M growth in North American sales and a £38.1M increase in European sales. Cost of sales also grew … Continue reading
Dechra Pharmaceuticals has now released their interim results for the year ending 2017. Revenues increased when compared to the first half of last year with a £37.4M growth in North American revenue (£25M attributable to the Brovel and Putney acquisitions) … Continue reading
Dechra Pharmaceuticals has now released its final results for the year ended 2016. Revenues increased when compared to last year with a £23.9M growth in North American revenue and a £20.2M increase in European revenue. Cost of inventories increased by … Continue reading
Dechra Pharmaceuticals has now released its interim results for the year ending 2016. Revenues increased when compared to the first half of last year with a £9.1M growth in North American revenues, aided by a strong US dollar, and a … Continue reading
Dechra has now released its final results for the year ended 2015. Overall revenues increased when compared to last year as a £3.8M decline in European revenue was more than offset by a £13.7M growth in North American revenue. Cost … Continue reading
Dechra Pharmaceuticals has now released its interim results for the year ending 2015. When compared to last year, revenues increased against a soft comparator during the first half of last year due to the £5.4M growth in sales from US … Continue reading
Dechra has now released its full year results for the year ending 2014. Revenues across both business segments increased, with European pharmaceuticals up £3.8M and US pharmaceuticals up £300K. Revenues also increased across most product categories with Food Animals the … Continue reading